comparemela.com

Latest Breaking News On - Pharmaceuticals company profile - Page 4 : comparemela.com

PMV Pharmaceuticals' (PMVP) Buy Rating Reaffirmed at HC Wainwright

HC Wainwright reiterated their buy rating on shares of PMV Pharmaceuticals (NASDAQ:PMVP – Free Report) in a research note published on Tuesday morning, Benzinga reports. HC Wainwright currently has a $5.00 target price on the stock. HC Wainwright also issued estimates for PMV Pharmaceuticals’ Q2 2024 earnings at ($0.31) EPS, Q3 2024 earnings at ($0.33) […]

Ohio
United-states
Craig-hallum
Pharmaceuticals-inc
Vanguard-group-inc
Pricet-rowe-associates-inc
Acadian-asset-management
Jacobs-levy-equity-management-inc
Pharmaceuticals-stock-down
Pharmaceuticals-company-profile
Jefferies-financial-group
Pharmaceuticals-daily

scPharmaceuticals Inc. to Post FY2026 Earnings of $0.80 Per Share, Leerink Partnrs Forecasts (NASDAQ:SCPH)

scPharmaceuticals Inc. (NASDAQ:SCPH – Free Report) – Analysts at Leerink Partnrs lifted their FY2026 EPS estimates for scPharmaceuticals in a research report issued on Tuesday, May 14th. Leerink Partnrs analyst R. Ruiz now anticipates that the company will post earnings of $0.80 per share for the year, up from their prior estimate of $0.75. The […]

Leerink-partnrs
Pharmaceuticals-daily
Brock-investment-advisors
Perkins-capital-management-inc
Thomasville-national-bank
Pharmaceuticals-stock-performance
Pharmaceuticals-inc
Nasdaq
Pharmaceuticals-company-profile
Investment-advisors
Free-report
Get-free-report

FY2027 Earnings Forecast for scPharmaceuticals Inc. Issued By HC Wainwright (NASDAQ:SCPH)

scPharmaceuticals Inc. (NASDAQ:SCPH – Free Report) – Stock analysts at HC Wainwright lowered their FY2027 EPS estimates for shares of scPharmaceuticals in a report issued on Wednesday, May 15th. HC Wainwright analyst D. Tsao now forecasts that the company will earn $1.95 per share for the year, down from their previous estimate of $2.25. HC […]

King-luther-capital-management-corp
Pharmaceuticals-daily
Rice-hall-james-associates
Pharmaceuticals-company-profile
Worth-venture-partners
Pharmaceuticals-stock
Capital-management
Nasdaq
Pharmaceuticals-inc
Free-report
Get-free-report

TRACON Pharmaceuticals (NASDAQ:TCON) Releases Quarterly Earnings Results, Misses Estimates By $0.13 EPS

TRACON Pharmaceuticals (NASDAQ:TCON – Get Free Report) posted its quarterly earnings results on Tuesday. The biopharmaceutical company reported ($1.33) EPS for the quarter, missing analysts’ consensus estimates of ($1.20) by ($0.13), Zacks reports. The company had revenue of $0.10 million during the quarter. During the same quarter in the previous year, the company earned ($7.20) […]

United-states
Pharmaceuticals-price-performance
Pharmaceuticals-inc
Tracon-pharmaceuticals
Pharmaceuticals-company-profile
Pharmaceuticals-daily
Get-free-report

scPharmaceuticals (NASDAQ:SCPH) Rating Reiterated by HC Wainwright

scPharmaceuticals (NASDAQ:SCPH) Rating Reiterated by HC Wainwright
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Pharmaceuticals-inc
Raymond-james-associates
Pharmaceuticals-price-performance
Capital-management
Tejara-capital-ltd
Worth-venture-partners
Pharmaceuticals-daily
Pharmaceuticals-company-profile
Nasdaq
Free-report
Pharmaceuticals-price
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.